Home patients
 

Keywords :   


Tag: patients

Health technology puts patients first

2014-09-23 01:00:34| BBC News | Business | UK Edition

The tech making life a little easier for patients

Tags: health technology patients puts

 

Merck Presents First Phase 3 Data in Japanese Patients for Omarigliptin, an Investigational Once-Weekly DPP-4 Inhibitor for Type 2 Diabetes

2014-09-17 15:31:00| Merck.com - Corporate News

Dateline City: WHITEHOUSE STATION, N.J. Omarigliptin significantly reduced HbA1c levels compared to placebo WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the presentation of the first data from the Phase 3 clinical development program for omarigliptin, Mercks investigational once-weekly DPP-4 inhibitor for the treatment of type 2 diabetes. In a study in Japanese patients, omarigliptin provided comparable efficacy and tolerability to Mercks once-daily DPP-4 inhibitor JANUVIA (sitagliptin) 50 mg, which is the standard starting dose for sitagliptin in Japan. Language: English Contact: MerckMedia:Pam Eisele, +1 (267) 305-3558Michael Close, +1 (267) 305-1221 or +1 (310) 617-1067orInvestors:Justin Holko, +1 (908) 423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: for type data japanese

 
 

Expert lectures doctors about hidden dangers of wireless radiation from patients' cell phones, Wifi

2014-09-11 16:49:51| Wireless - Topix.net

An American public health expert will lecture Canadian doctors tomorrow about the hidden dangers of wireless radiation from their patients' cell phones, Wifi and other wireless consumer devices. "We've shown that men who keep phones in their pockets can have problems with infertility and possibly impotence ," said Dr. Devra Davis, PhD, President of Environmental Health Trust.

Tags: cell phones wireless expert

 

Keryx pill for kidney disease patients cleared, but with safety warnings attached, shares fall

2014-09-05 22:05:57| Biotech - Topix.net

Keryx Biopharmaceuticals shares fell Friday as the company received U.S. approval for its pill to treat kidney disease complications but the clearance required unexpected safety warnings. The Food and Drug Administration approved the company's ferric citrate drug to treat patients on dialysis with hyperphosphatemia, or elevated levels of phosphates, which can increase the risk of heart disease, bone density problems and death.

Tags: fall safety attached disease

 

Boston Strategics Corporation Initiates A Phase 1 Clinical Trial Of The Anti-Cancer Agent FF-10501' For FUJIFILM In Patients With Advanced Hematologic Malignancies

2014-09-03 11:37:54| drugdiscoveryonline Home Page

Boston Strategics Corporation (BSC), a primary global strategic drug development provider for FUJIFILM Pharmaceuticals U.S.A., Inc. (FPHU), has begun a Phase 1 clinical trial of FUJIFILM’s anti-cancer agent FF-10501 in the United States in patients with advanced hematologic malignancies, such as relapsed or refractory high-risk myelodysplastic syndromes (MDS)

Tags: with advanced corporation agent

 

Sites : [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] next »